| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.7 | $5k-$25k | 0.00 |
Summary
A vulnerability classified as critical was found in IBM QRadar SIEM 7.3.2. The impacted element is an unknown function. The manipulation results in improper authentication. This vulnerability is known as CVE-2019-4210. It is possible to launch the attack remotely. No exploit is available.
Details
A vulnerability, which was classified as critical, was found in IBM QRadar SIEM 7.3.2 (Log Management Software). Affected is an unknown function. The manipulation with an unknown input leads to a improper authentication vulnerability. CWE is classifying the issue as CWE-287. When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
IBM QRadar SIEM 7.3.2 could allow a user to bypass authentication exposing certain functionality which could lead to information disclosure or modification of application configuration. IBM X-Force ID: 158986.
The bug was discovered 04/04/2019. The weakness was published 04/08/2019 (Website). The advisory is shared for download at exchange.xforce.ibmcloud.com. This vulnerability is traded as CVE-2019-4210 since 01/03/2019. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $5k-$25k (estimation calculated on 08/27/2023). It is expected to see the exploit prices for this product increasing in the near future.
The vulnerability was handled as a non-public zero-day exploit for at least 4 days. During that time the estimated underground price was around $5k-$25k. The commercial vulnerability scanner Qualys is able to test this issue with plugin 371741 (IBM QRadar SIEM Authentication Bypass Vulnerability (ibm10879913)).
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.7VulDB Meta Temp Score: 7.7
VulDB Base Score: 7.3
VulDB Temp Score: 7.3
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 8.1
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Improper authenticationCWE: CWE-287
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Qualys ID: 🔍
Qualys Name: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/03/2019 🔍04/04/2019 🔍
04/08/2019 🔍
04/09/2019 🔍
08/27/2023 🔍
Sources
Vendor: ibm.comAdvisory: exchange.xforce.ibmcloud.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2019-4210 (🔍)
GCVE (CVE): GCVE-0-2019-4210
GCVE (VulDB): GCVE-100-133140
X-Force: 158986
SecurityFocus: 107859
Entry
Created: 04/09/2019 08:33Updated: 08/27/2023 14:33
Changes: 04/09/2019 08:33 (60), 05/27/2020 15:35 (1), 08/27/2023 14:33 (4)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.